Supplementary Material for: Primary cardiac epithelioid angiosarcoma with sustained remission following surgical resection: A case report
收藏DataCite Commons2023-09-12 更新2024-08-18 收录
下载链接:
https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Primary_cardiac_epithelioid_angiosarcoma_with_sustained_remission_following_surgical_resection_A_case_report/24071037
下载链接
链接失效反馈官方服务:
资源简介:
Epithelioid angiosarcoma is an extremely rare subtype of cardiac angiosarcoma that is highly aggressive and associated with poor prognosis. Due to its rare nature, the epidemiology and pathogenesis of this disease are not well-known. Thus, effective diagnostic and treatment modalities are limited. Here, we report a case of a primary epithelioid angiosarcoma in a patient who was treated successfully with surgical resection. A 45-year-old woman who initially presented with chronic systemic symptoms and severe anemia and subsequently developed new onset atrial fibrillation with rapid ventricular rate was found to have a right-sided cardiac mass with a large pericardial effusion. Several years prior to presentation, she was treated for localized papillary thyroid cancer with Gc protein-derived macrophage-activating factor (Gc-MAF) therapy after declining thyroidectomy. After initial work-up of her cardiac mass, including a transthoracic echocardiogram and cardiac MRI, she was transferred to an outside hospital where her mass was surgically resected. She was found to have stage IIIA high-grade epithelioid angiosarcoma involving the inferior vena cava, right atrium, and pericardium. She subsequently had complete resolution of her pericardial effusion and anemia and continues to have good performance status thirteen months after her excellent surgical outcome without evidence of recurrence. This unique case contributes to our knowledge of epithelioid cardiac angiosarcoma, of which limited number of cases have been reported. It highlights a favorable outcome following surgical resection of a rare, life-threatening primary cardiac tumor.
提供机构:
Karger Publishers
创建时间:
2023-09-12



